Methyldopa- Sembrina 250 Mg

Information About Methyldopa- Sembrina 250 Mg

About Methyldopa- Sembrina 250 Mg

The Medicine Brand Sembrina 250 mg is manufactured by Sanofi Aventis Pharma India and mainly contents the generic drug Methyldopa.

Pakaging

10 Tablet

Active Ingredients For Methyldopa- Sembrina 250 Mg

Methyldopa 250 mg

Diseases List For Which Methyldopa- Sembrina 250 Mg Is Prescribed

This Drug Is Prescribed For Mild to moderate hypertension

Other Significations For Methyldopa- Sembrina 250 Mg

This Medication This medication is an alpha2 receptor agonist prescribed for hypertension

Precautions To Be Taken Before Methyldopa- Sembrina 250 Mg

The use of amantadine Symmetrel benztropine Cogentin procyclidine Kemadrin or trihexyphenidyl Artane with carbidopalevodopa can enhance the anti Parkinsons effects of levodopa Droperidol haloperidol Haldol loxapine Loxitane metoclopramideReglan phenothiazines such as prochlorperazine Thorazine thioxanthenes as thiothixene Navane inhibit dopamine in the brain These drugs therefore can worsen Parkinsons disease and reverse the beneficial effects of levodopa Methyldopa Aldomet and reserpine also can interfere with the beneficial actions of carbidopalevodopa and can increase the risk of side effects The occurrence of postural hypotension reduced blood pressure when standing from a sitting or lying down position may increase when carbidopalevodopa is combined with drugs that reduce blood pressurePhenytoin Dilantin can increase the breakdown of carbidopalevodopa reducing its effectiveness Use of carbidopalevodopa with monoamine oxidase inhibitors MAOIs antidepressants for example isocarboxazid Marplan phenelzine Nardil tranylcypromine Parnate and procarbazine Matulane can result in severe and dangerous elevations in blood pressure MAOIs should be stopped 24 weeks before starting carbidopalevodopa therapy

Major Conditions And Care

Pregnancy And Methyldopa- Sembrina 250 Mg

Can We Take Methyldopa- Sembrina 250 Mg During Pregnancy?

Pregnancy Class C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and wellcontrolled studies in humans but potential benefits may warrant use of the drug in pregnant women despite potential risks

Lactation And Methyldopa- Sembrina 250 Mg

Can We Use Methyldopa- Sembrina 250 Mg During Lactation

Lactation Class L5 Studies in breastfeeding mothers have demonstrated that there is significant and documented risk to the infant based on human experience or it is a medication that has a high risk of causing significant damage to an infant The risk of using the drug in breastfeeding women clearly outweighs any possible benefit from breastfeeding The drug is contraindicated in women who are breastfeeding an infant

Side Effects Of Methyldopa- Sembrina 250 Mg

Nausea stomach upset skin rash acute toxicity

More Danger Effects Fatal Effect Due To Overdose Of Methyldopa- Sembrina 250 Mg